Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- JBIO
- Price
- 11.48
- Stock movement down
- -0.98 (-7.87%)
- Company name
- Jade Biosciences, Inc.
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 370.07M
- Ent value
- -
- Price/Sales
- -
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-11-20
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
JBIO does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | - |
| EV to Sales | - |
iO Charts is a Seeking Alpha partner
FINANCIALS
Income statement
Loading...
Income statement data
| Revenue (TTM) | - |
| Gross profit (TTM) | - |
| Operating income (TTM) | - |
| Net income (TTM) | - |
| EPS (TTM) | - |
| EPS (1y forward) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 220.94M |
| Net receivables | 0.00 |
| Total current assets | 222.98M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 924.00K |
| Total assets | 223.97M |
| Accounts payable | 7.59M |
| Short/Current long term debt | 792.00K |
| Total current liabilities | 21.62M |
| Total liabilities | 22.41M |
| Shareholder's equity | 0.00 |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | - |
| Capital expenditures (TTM) | - |
| Free cash flow (TTM) | - |
| Dividends paid (TTM) | - |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 12.65 |
| Daily high | 13.25 |
| Daily low | 11.47 |
| Daily Volume | 143K |
| All-time high | 12.65 |
| 1y analyst estimate | 16.67 |
| Beta | - |
| EPS (TTM) | - |
| Dividend per share | 0.00 |
| Ex-div date | 29 Apr 2025 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| JBIO | S&P500 | |
| Current price drop from All-time high | -9.25% | -5.07% |
| Highest price drop | -12.17% | -19.00% |
| Date of highest drop | 6 Nov 2025 | 8 Apr 2025 |
| Avg drop from high | -3.01% | -2.73% |
| Avg time to new high | 3 days | 6 days |
| Max time to new high | 14 days | 89 days |
COMPANY DETAILS
Marketcap
370.07M
Marketcap category
Small-cap
Description
Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. The company develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. It also develops JADE201 and JADE-003, which are in preclinical development stage. The company has a collaboration agreement with Paragon Therapeutics, Inc. Jade Biosciences, Inc. was founded in 2024 and is headquartered in Waltham, Massachusetts.
Employees
30
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner